Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Healthy diet, moderate alcohol may be associated with decreased risk of CKD in diabetes patients

Eating a healthy diet and drinking a moderate amount of alcohol may be associated with decreased risk or progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

13 Aug 2013

Parents effort improves healthy behaviors of their children at schools

Because children spend most of their time in classrooms, schools are an ideal setting for healthy behaviors to be taught and modeled. Therefore, parents are speaking up and getting involved in an effort to improve the health of their children at schools.

12 Aug 2013

Weight and mortality relationship appears to be stronger in adults without diabetes

Researchers ask diabetes status be taken into account in population studies that link weight and mortality. The relationship between body mass index (BMI) appears to be stronger in adults without diabetes than those with existing diabetes. These findings¹ are published in the Journal of General Internal Medicine² in a study by Chandra Jackson of the Harvard School of Public Health and colleagues.

12 Aug 2013

Person with type 2 diabetes may spend nearly $85,500 to treat the disease

A person with type 2 diabetes may spend an average of nearly $85,500 to treat the disease and its complications over his or her lifetime, reports a new study in the American Journal of Preventive Medicine.

9 Aug 2013

UAH invents smart pill bottle that notifies you to take your medications

Patented at The University of Alabama in Huntsville, (UAH), a smart pill bottle that notifies you to take your medications or reminds you if you missed a dose could be en route to medicine cabinets as soon as 2015.

8 Aug 2013

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.

8 Aug 2013

Personalized models for preventive health care services

With physicians facing increasing demands on their time, it can be extremely difficult to prioritize which preventive care methods should be used for their patients. Now, two researchers at NYU Langone Medical Center have developed a mathematical model that will save time, lead to enhanced care, and potentially save lives.

6 Aug 2013

Research links high prevalence of Type 2 diabetes in the American South with economic conditions

The strikingly high prevalence of Type 2 diabetes in the American South can be partially traced to rapid economic growth between 1950 and 1980, new research suggests.

6 Aug 2013

Mothers who breastfeed may have lower risk of Alzheimer's

The report, newly published in the Journal of Alzheimer's Disease, suggests that the link may be to do with certain biological effects of breastfeeding. For example, breastfeeding restores insulin tolerance which is significantly reduced during pregnancy, and Alzheimer's is characterised by insulin resistance in the brain.

6 Aug 2013

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

3 Aug 2013

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Boehringer Ingelheim and Eli Lilly and Company today announced enrollment of the first patient into a cardiovascular and renal outcomes trial for linagliptin (Trajenta).

1 Aug 2013

Bariatric procedures can lead to rapid, safe and permanent weight loss in obese patients

A recent article from CBS News reports on a U.S. government study that found the amount of time a person has been obese can play a significant role in how high their risk of heart disease may be.

1 Aug 2013

Genetics could help women at risk of developing gestational diabetes

New Northwestern Medicine- research on the genetics of diabetes could one day help women know their risk for developing gestational diabetes before they become pregnant -- and lead to preventive measures to protect the health of offspring.

1 Aug 2013

Stress during pregnancy can increase baby’s risk of obesity and type 2 diabetes

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, shows that passively coping offspring of mothers stressed during their pregnancy were at risk to develop obesity and type 2 diabetes.

30 Jul 2013

FDA accepts NDA for MNK-795 oral formulation

Depomed, Inc. (NASDAQ: DEPO) announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) from Mallinckrodt (NYSE: MNK) for MNK-795.

30 Jul 2013

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

Why do some innovations spread so swiftly and others so slowly? Consider the very different trajectories of surgical anesthesia and antiseptics. ... On October 16, 1846, at Massachusetts General Hospital, Morton administered his gas through an inhaler in the mouth of a young man undergoing the excision of a tumor in his jaw. ... By February, anesthesia had been used in almost all the capitals of Europe, and by June in most regions of the world.

26 Jul 2013

FDA acknowledges receipt of NDA resubmission of dapagliflozin drug for treatment of type 2 diabetes

AstraZeneca (NYSE: AZN) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for investigational drug dapagliflozin for the treatment of adults with type 2 diabetes.

26 Jul 2013

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

Essentially, what an artificial pancreas would be doing is taking the blood glucose results from a continuous monitor and taking the data that the patient puts in about the amount she/he is eating, and then adjusting the amount of insulin being delivered by the pump based on a mathematical formula that would be very personalized to that patient.

25 Jul 2013

HONEI review shows that high glycemic index foods can exacerbate acne

A review carried out by the University of Hull has shed new light on the relationship between acne and diet. Published in Dermatological Nursing, the comprehensive review assesses the latest evidence and findings about the effects of food and nutrition on acne and suggest that high glycemic index foods such as milk could exacerbate the skin condition.

25 Jul 2013

Study provides more reliable estimate of the likely risk of disability associated with diabetes

Older adults with diabetes are at least 50% more likely to have a physical disability than those without diabetes, according to the results of a new systematic review and meta-analysis published in The Lancet Diabetes & Endocrinology.

25 Jul 2013

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Healthy diet, moderate alcohol may be associated with decreased risk of CKD in diabetes patients

Parents effort improves healthy behaviors of their children at schools

Weight and mortality relationship appears to be stronger in adults without diabetes

Person with type 2 diabetes may spend nearly $85,500 to treat the disease

UAH invents smart pill bottle that notifies you to take your medications

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

Personalized models for preventive health care services

Research links high prevalence of Type 2 diabetes in the American South with economic conditions

Mothers who breastfeed may have lower risk of Alzheimer's

IQWiG dossier assessment finds no added benefit of lixisenatide

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Bariatric procedures can lead to rapid, safe and permanent weight loss in obese patients

Genetics could help women at risk of developing gestational diabetes

Stress during pregnancy can increase baby’s risk of obesity and type 2 diabetes

FDA accepts NDA for MNK-795 oral formulation

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

FDA acknowledges receipt of NDA resubmission of dapagliflozin drug for treatment of type 2 diabetes

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

HONEI review shows that high glycemic index foods can exacerbate acne

Study provides more reliable estimate of the likely risk of disability associated with diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in